The Sustainable Healthcare Podcast Podcast Por Care Pathway Consulting Aps arte de portada

The Sustainable Healthcare Podcast

The Sustainable Healthcare Podcast

De: Care Pathway Consulting Aps
Escúchala gratis

Learn the dos and don'ts of green innovation from experienced industry leaders. Your hosts are Frederik Dam van Deurs and Joachim Almdal.Copyright Care Pathway Consulting Aps Economía
Episodios
  • 100 - Liz Willetts on Biodiversity x Healthcare

    100 - Liz Willetts on Biodiversity x Healthcare
    Apr 11 2026
    Liz Willetts has spent 20 years at the intersection of nature and health.In this conversation, she explains why nearly 200 governments have been asking for integrated biodiversity-health indicators for over a decade, and why the scientific community still hasn't delivered them. About the guest: Liz Willetts is a science-policy expert on global governance of the health-environment nexus.She has served as Planetary Health Policy Director at Harvard T.H. Chan School of Public Health, science-policy advisor to the Convention on Biological Diversity, and is a Team Leader, Editor and Writer at IISD's Earth Negotiations Bulletin. She is also a primary care clinician with experience in Micronesia, Central America, and the US. Key takeaways:196 countries have called for biodiversity-health metrics through the Convention on Biological Diversity for decades, but the health and environmental science communities remain siloed, and integrated indicators still don't existEven senior clinicians with 10+ years of experience may not know how to define "biodiversity", pointing to a fundamental gap in medical educationThe post-consumption lifecycle of pharmaceuticals, what happens when drugs exit patients and enter wastewater, represents a massive blind spot in both environmental monitoring and clinical trainingTimestamps:00:00 - Introduction and Liz's background03:00 - How environmental decisions are public health decisions08:00 - Air quality policy as a biodiversity example (Copenhagen low emission zones)12:00 - The decade-long gap: governments asking for indicators nobody has built18:00 - The grand rounds anecdote: a clinician who didn't know "biodiversity"22:00 - Plant blindness and the siloing of scientific education26:00 - Chronic kidney disease carbon footprint and biodiversity30:00 - Practical advice for national biodiversity-health strategies36:00 - Held v. State of Montana: climate litigation as a model for ecosystem values42:00 - The nature footprint of healthcare: a blank canvas46:00 - Pharmaceutical pollution and the end-of-life gap50:00 - What gives Liz hope References mentioned:Liz Willetts, "Metrics for Biodiversity and Health Policy Integration," PLOS Global Public Health, 2025: PubMedConvention on Biological Diversity (CBD) and the Kunming-Montreal Global Biodiversity Framework (2022)Global Action Plan on Biodiversity and Health, adopted at CBD COP16 (2024)Held v. State of Montana: Climate Case ChartPlant blindness (academic concept): Literature review 1999-2024Pharma Pollution Hub / Kelly Thornber: pharmapollution.orgGlobal Biodiversity Framework: https://www.cbd.int/gbfGlobal Action Plan on Biodiversity and Health:https://www.cbd.int/health/GAP.shtmlLinks:Liz Willetts on LinkedIn: https://www.linkedin.com/in/liz-willetts-2336749/IISD Earth Negotiations Bulletin: https://enb.iisd.org/Joachim Almdal on LinkedIn: https://www.linkedin.com/in/joachim-espeland-almdal-017a6973/Frederik van Deurs on LinkedIn: https://www.linkedin.com/in/frederikvandeurs/Care Pathway Consulting: https://carepathwayconsulting.comYou might also enjoy:Episode 092: Planetary Boundaries & Health with Mia Heide (WELA)Episode 098: Tackling Pharmaceutical Pollution: A Systems-Based ApproachEpisodes 023/024: The Biodiversity Crisis in Healthcare (two-parter)
    Más Menos
    52 m
  • 099 Integrating Sustainability into business - a pharma supplier perspective with Marwin Krull

    099 Integrating Sustainability into business - a pharma supplier perspective with Marwin Krull
    Apr 1 2026
    Meeting Pharma's Rising Sustainability Demands:
    Marwin Krull on Körber Pharma and the Alliance to Zero Marwin Krull is Sustainability Lead for the Pharma business area at Körber Pharma and Vice President of the Alliance to Zero. He explains how pharma customer requests have evolved from broad questions about EcoVadis scores and green electricity to specific demands around product carbon footprints, SBTi alignment, CDP thresholds, and ISO-based LCAs. Key takeaways:
    • Pharma sustainability demands have matured fast - customers now ask for verified GHG inventories and product-level carbon footprints, not just policies
    • Closing the gap between group sustainability strategy and day-to-day operations requires internal coordination, sales enablement, and e-learning - not just a target
    • The Alliance to Zero (founded 2021) is driving practical collaboration across the autoinjector value chain, including a syringe packaging redesign and "green premium" transparency research with TU Hamburg
    Timestamps:
    00:00 - Customer sustainability pressure
    00:37 - Meet Marwin Krull and his roles
    03:35 - How customer demands evolved
    07:13 - What Körber Pharma does
    10:21 - Inside the sustainability role
    14:58 - Sales enablement and training
    18:05 - What is Alliance to Zero
    21:30 - Collaboration wins and research
    25:33 - Practical advice and wrap-up
    Links: Marwin Krull on LinkedIn | Alliance to Zero | Körber Pharma Hosts: Joachim Almdal on LinkedIn | Frederik van Deurs on LinkedIn | Care Pathway Consulting "Customers went from asking 'do you have green electricity?' to asking for ISO-verified product carbon footprints in just a few years." - Marwin Krull
    Más Menos
    28 m
  • 098 - Tackling Pharmaceutical Pollution: A Systems-Based Approach

    098 - Tackling Pharmaceutical Pollution: A Systems-Based Approach
    Feb 3 2026
    Tackling Pharmaceutical Pollution: A Systems-Based Approach

    In this episode of the Sustainable Healthcare Podcast, host Frederik Dam van Deurs welcomes Kelly Thornber, a researcher and advocate for addressing pharmaceutical pollution. Kelly shares her journey from working in Bangladesh to identifying pharmaceutical pollution as a global issue, and discusses the systems-based approach needed to mitigate its risks to public and environmental health.

    Episode Summary
    Kelly Thornber discusses the complexity of pharmaceutical pollution and the need for a systems-based strategy to address it. She highlights the importance of understanding the entire lifecycle of pharmaceuticals, from manufacture to disposal, and the role of various stakeholders in creating a sustainable solution.

    Key Topics Covered
    1. Introduction to Kelly Thornber:
      • Kelly discusses her background and how she became interested in pharmaceutical pollution while working in Bangladesh.
      • Her journey into sustainability and how her department is driving change within the company.

    2. Understanding Pharmaceutical Pollution:
      • The importance of addressing pharmaceutical pollution and its impact on public and environmental health.
      • The complexity of the pharmaceutical system and the need for a systems-based approach to mitigate risks.

    3. The Role of the Pharma Pollution Hub:
      • Kelly’s work with the Pharma Pollution Hub and their efforts to advocate for changes in the pharmaceutical industry.
      • The need for independent facilitation and oversight to drive meaningful change.

    4. Identifying Intervention Points:
      • The 37 intervention points identified in Kelly’s paper and the importance of starting with actionable steps.
      • The role of stakeholders in implementing these interventions and the need for collaboration.
    Notable Quotes
    • "Pharmaceuticals are designed to be biologically active, and that means they can have physiological effects in non-target species." - Kelly Thornber
    • "We need to take a systems approach to address the complex issue of pharmaceutical pollution." - Kelly Thornber
    Resources Mentioned
    • Pharma Pollution Hub: Pharma Pollution Hub Website
    • Pharmaceutical Pollution Paper: Read the Paper
    Call to Action
    • Share your thoughts: What role should the pharmaceutical industry play in addressing pollution? Connect with Frederik on LinkedIn to share your insights.
    • Subscribe and Share: Help spread the word about sustainable healthcare by subscribing to the podcast and sharing this episode with your network.
    Host: Frederik Dam van Deurs Guest: Kelly Thornber, Researcher and Advocate for Pharmaceutical Pollution
    Más Menos
    39 m
Todavía no hay opiniones